RFI: National Strategic Plan for Advanced Manufacturing Letter
This comment letter fromAdvaMed® responds to the OSTP’s Request for Information on National Strategic Plan for Advanced Manufacturing (“OSTP RFI”).
Resource Library
Access our full library of guidance, white papers, and other resources developed by and for the medical technology industry.
Filter By:
AdvaMed® Advancements: Q3 2025 Report
AdvaMed® Advancements: Q3 2025 Report. Amid an increasingly charged political environment,AdvaMed® remained a steady, persuasive voice for medtech innovation. From mobilizing rapid action on the Section 232 investigation to advancing…
AdvaMed® Device and Diagnostics Compliance Group Benchmarking | Meals
AdvaMed® periodically compiles benchmarking data on Member companies’ policies regarding the provision of meals and refreshments to U.S. Health Care Professionals to assist companies in understanding industry trends and practices…
The Economic Impact of the Medical Technology Industry 2024
Explore AdvaMed’s 2024 Economic Impact Report, developed by Frost & Sullivan, highlighting medtech’s vital contributions to the U.S. economy
AdvaMed® Comments on OSTP Request for Information: Regulatory Reform on Artificial Intelligence
AdvaMed® Comments on OSTP Request for Information: Regulatory Reform on Artificial Intelligence
Listen to AdvaMed®'s Podcast
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed® Code of Ethics®
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Tariff-related Litigation Update – 9/12
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through August 15, 2025.
AdvaMed® Device and Diagnostics Compliance Group Benchmarking | Compliance Training
AdvaMed® periodically compiles benchmarking data on Member companies’ compliance policies regarding travel and lodging for U.S. Health Care Professionals to assist companies in understanding industry trends and practices when the…
Tariff-related Litigation Update – 9/5
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through August 15, 2025.